EMDIN, MICHELE
 Distribuzione geografica
Continente #
NA - Nord America 90.304
EU - Europa 46.025
AS - Asia 41.995
SA - Sud America 9.345
Continente sconosciuto - Info sul continente non disponibili 1.332
AF - Africa 1.075
OC - Oceania 83
Totale 190.159
Nazione #
US - Stati Uniti d'America 84.547
SG - Singapore 15.127
IT - Italia 11.608
RU - Federazione Russa 10.963
CN - Cina 10.443
GB - Regno Unito 8.528
BR - Brasile 7.234
VN - Vietnam 6.009
CA - Canada 3.447
DE - Germania 3.022
HK - Hong Kong 3.016
BD - Bangladesh 2.746
UA - Ucraina 2.669
FR - Francia 1.637
DK - Danimarca 1.592
SE - Svezia 1.538
FI - Finlandia 1.102
IN - India 963
MX - Messico 776
IE - Irlanda 771
AR - Argentina 719
PL - Polonia 716
NL - Olanda 564
TR - Turchia 512
ID - Indonesia 438
IL - Israele 425
EC - Ecuador 390
ZA - Sudafrica 370
ES - Italia 363
JP - Giappone 343
IQ - Iraq 339
PK - Pakistan 298
CO - Colombia 267
CR - Costa Rica 252
VE - Venezuela 207
AT - Austria 202
HN - Honduras 177
MA - Marocco 173
GT - Guatemala 164
TT - Trinidad e Tobago 164
SV - El Salvador 161
UZ - Uzbekistan 159
CL - Cile 151
EU - Europa 149
AE - Emirati Arabi Uniti 139
LT - Lituania 137
SA - Arabia Saudita 132
NI - Nicaragua 129
PY - Paraguay 129
PR - Porto Rico 127
JM - Giamaica 124
MY - Malesia 110
CW - ???statistics.table.value.countryCode.CW??? 105
EG - Egitto 103
PE - Perù 98
PH - Filippine 98
KE - Kenya 91
GP - Guadalupe 85
TN - Tunisia 84
KR - Corea 77
DZ - Algeria 71
UY - Uruguay 71
JO - Giordania 68
CH - Svizzera 63
BO - Bolivia 62
BE - Belgio 61
IR - Iran 60
NP - Nepal 56
SK - Slovacchia (Repubblica Slovacca) 55
AU - Australia 53
AZ - Azerbaigian 49
PT - Portogallo 47
RO - Romania 47
DO - Repubblica Dominicana 43
KZ - Kazakistan 41
AL - Albania 40
CZ - Repubblica Ceca 40
TW - Taiwan 37
TH - Thailandia 36
ET - Etiopia 34
OM - Oman 33
HU - Ungheria 29
KG - Kirghizistan 29
BB - Barbados 26
GR - Grecia 26
PA - Panama 25
AM - Armenia 24
LB - Libano 23
PS - Palestinian Territory 22
RS - Serbia 22
CI - Costa d'Avorio 21
SN - Senegal 21
GE - Georgia 20
KW - Kuwait 19
NO - Norvegia 19
NZ - Nuova Zelanda 19
SI - Slovenia 18
LV - Lettonia 17
MD - Moldavia 17
QA - Qatar 17
Totale 188.690
Città #
Dallas 14.001
Singapore 7.658
San Jose 6.251
Ashburn 6.140
Southend 5.518
Beijing 4.112
Council Bluffs 4.054
Woodbridge 2.878
Hong Kong 2.736
Chandler 2.556
Ann Arbor 2.548
Houston 2.417
Los Angeles 2.406
Moscow 1.995
Chicago 1.917
Fairfield 1.915
San Mateo 1.857
Milan 1.754
Ho Chi Minh City 1.732
Falls Church 1.553
Seattle 1.364
New York 1.356
Dearborn 1.328
Jacksonville 1.227
Rome 1.216
The Dalles 1.195
Wilmington 1.173
Cambridge 1.163
Hanoi 1.086
Santa Clara 1.052
Buffalo 968
Ottawa 967
São Paulo 817
Hefei 806
Lauterbourg 798
Boardman 786
Salt Lake City 769
Phoenix 755
Dublin 742
Portsmouth 685
Stevenage 685
Pisa 675
Warsaw 644
Dong Ket 641
Helsinki 554
Lawrence 527
Brooklyn 504
Montreal 449
Orem 446
Beauharnois 444
Tampa 439
Munich 412
Montréal 406
London 385
Elk Grove Village 371
Florence 360
Tel Aviv 355
Mexico City 352
Toronto 324
Naples 322
Frankfurt am Main 301
Atlanta 293
Tokyo 293
Denver 286
Columbus 274
Chennai 268
Rio de Janeiro 253
San Diego 241
Johannesburg 234
Stockholm 234
Istanbul 231
Amsterdam 226
Poplar 221
Figino 219
Bologna 218
Turin 212
Da Nang 211
Nuremberg 210
Haiphong 197
Boston 183
Miami 183
San José 181
Sterling 166
Lancaster 163
Redwood City 161
Old Bridge 158
Washington 155
San Francisco 153
Belo Horizonte 146
Brasília 144
Tashkent 144
Manchester 140
Palermo 139
San Salvador 134
Lappeenranta 132
Guangzhou 131
Guayaquil 131
Genoa 127
Managua 122
Biên Hòa 121
Totale 113.282
Nome #
Prognostic value of soluble ST2 in AL and TTR cardiac amyloidosis: a multicenter study 1.863
N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis 1.734
Cardiac remodelling - Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 1.610
Congestion in heart failure: a circulating biomarker-based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of Cardiology 1.375
Cardiac remodelling - Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 916
High prevalence of wild-type transthyretin cardiac amyloidosis in older adults with carpal tunnel syndrome, heart failure or increased left ventricular mass: The CAPTURE study 754
Left ventricular outflow tract velocity-time integral improves outcome prediction in patients with secondary mitral regurgitation 654
Patient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY study 633
A cross-correlational analysis between electroencephalographic and end-tidal carbon dioxide signals: Methodological issues in the presence of missing data and real data results 533
E-Health in Tuscany Inner Areas: The PROXIMITY-CARE Approach 520
Impact of GFR Estimation Formulas on MECKI Score Performance and Prognostic Accuracy in Heart Failure: The MECKI-RENAL Study 512
[ANMCO/ELAS/SIBioC Consensus document: Recommendations for the use of cardiac biomarkers in heart failure patients] 511
Value of the HFA-PEFF and H2FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis 486
[The use of PROMs (patient-reported outcome measures) and PREMs (patient-reported experience measures) in Cardiology: current state and applications to improve patient care] 481
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 470
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liver disease. 445
[18F]-Florbetaben PET/CT for Differential Diagnosis Among Cardiac Immunoglobulin Light Chain, Transthyretin Amyloidosis, and Mimicking Conditions 435
A simple echocardiographic score to rule out cardiac amyloidosis 434
A simple echocardiographic score to rule out cardiac amyloidosis 413
Prognostic Significance of Central Apneas Throughout a 24-Hour Period in Patients With Heart Failure 412
b-Gamma-glutamyltransferase activity in human vulnerable carotid plaques. 411
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liverdisease. 404
Trastuzumab cardiotoxicity and drug cardioprotection in healthy and cardiac dysfunction mouse models 402
Impaired HDL Cholesterol Function and High Interleukin-1ß Levels Hold Prognostic Value after ST-elevation Myocardial Infarctio 401
Intelligent data retrieval system as a decision support in cardiology in an Intranet environment 399
An Open System for Managing Long Term ECG Recordings 398
Cartella clinica automatizzata per il reparto di cardiologia 391
Meteorin-like protein is associated with a higher risk profile and predicts a worse outcome in patients with STEMI 389
Cardiac biomarker testing in the clinical laboratory: Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides 389
An open computational toolbox to analyze multi- and single-unit sympathetic nerve activity in microneurography 384
Building medical knowledge from real world registries: The case of heart failure 381
Abnormal T2-STIR magnetic resonance in hypertrophic cardiomyopathy: A marker of advanced disease and electrical myocardial instability 378
"Targeting and Treating Apneas" in "The Breathless Heart: Apneas in Heart Failure" 372
The Fondazione Toscana Gabriele Monasterio app: a digital health system to improve wellbeing of inpatients with heart or lung disease 368
Antithrombotic strategies in the catheterization laboratory for patients with acute coronary syndromes undergoing percutaneous coronary interventions: Insights from the EmploYEd antithrombotic therapies in patients with acute coronary Syndromes HOspitalized in Italian cardiac care units Registry 368
A simple method for measuring baroreflex sensitivity holds prognostic value in heart failure 365
"To Breathe, or Not to Breathe: That Is the Question" in "The Breathless Heart: Apneas in Heart Failure" 363
Central sleep apnea and cardiovascular disease state-of-the-art 362
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 361
[Central apneas and cardiovascular diseases] 359
Adaptive servo-ventilation therapy does not favourably alter sympatho-vagal balance in sleeping patients with systolic heart failure and central apnoeas: Preliminary data 358
A role for gamma-glutamyltransferase in pathogenesis and evolution of cardiovascular diseases. 356
Etiology, clinical presentation, and management of left main coronary artery aneurysms 355
Markers of fibrosis, inflammation, and remodeling pathways in heart failure 352
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers 352
La neuropatia diabetica 351
Prognostic Impact of QRS Axis Deviation in Patients Treated with Cardiac Resynchronization Therapy 350
Comparison between BNP values measured in capillary blood samples with a POCT method and those measured in plasma venous samples with an automated platform 348
Myocardial signal intensity decay after gadolinium injection: a fast and effective method for the diagnosis of cardiac amyloidosis 348
Prediction of the chemoreflex gain by common clinical variables in heart failure 348
N-terminal fragment of B-type natriuretic peptide predicts coexisting subclinical heart and vessel disease 348
Abnormal hyperventilation in patients with hepatic cirrhosis: Role of enhanced chemosensitivity to carbon dioxide. 346
Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals 344
Measurement of myocardial amyloid deposition in systemic amyloidosis: insights from cardiovascular magnetic resonance imaging 344
Peripheral reflex feedbacks in chronic heart failure: Is it time for a direct treatment? 343
A novel echocardiographic method for estimation of pulmonary artery wedge pressure and pulmonary vascular resistance 343
Cocaine assumption and transient myocardial edema in asymptomatic cocaine heavy-users 342
Gender and age normalization and ventilation efficiency during exercise in heart failure with reduced ejection fraction 341
Preliminary usability assessment for a novel robotic interface for remote Doppler-echocardiography 339
[18F]-florbetaben PET/CT is sensitive for cardiac AL amyloidosis 339
Treating chemoreflex in heart failure: modulation or demolition? 338
Amyloid deposits and fibrosis on left ventricular endomyocardial biopsy correlate with extracellular volume in cardiac amyloidosis 337
Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches 336
Role of tissue characterization by Cardiac Magnetic Resonance in the diagnosis of constrictive pericarditis 334
Influence of central apneas and chemoreflex activation on pulmonary artery pressure in chronic heart failure 334
Usefulness of late gadolinium enhancement MRI combined with stress imaging in predictive significant coronary stenosis in new-diagnosed left ventricular dysfunction 331
The calculation of the cardiac troponin T 99th percentile of the reference population is affected by age, gender, and population selection: A multicenter study in Italy. 329
Arterial thrombo-embolic events in cardiac amyloidosis: a look beyond atrial fibrillation 327
Clinical and prognostic significance of central and obstructive apnoeas in patients with transthyretin cardiac amyloidosis 326
Adrenergic activation in heart failure: blockade or rebalance? 326
Eligibility for vericiguat in a real‐world, contemporary heart failure population 324
Effects of smoking in patients treated with cardiac resynchronization therapy 324
[Treatment of cardiac fibrosis: from neurohormonal antagonists to CAR-T cells] 322
N-terminal prob-type natriuretic peptide is a marker of vascular remodelling and subclinical atherosclerosis in asymptomatic hypertensives 322
Aortic elasticity indices by magnetic resonance predict progression of ascending aorta dilation 322
[Ten perspectives for research and innovation in cardiac amyloidosis] 321
Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals. 321
Sex Profile and Risk Assessment With Cardiopulmonary Exercise Testing in Heart Failure: Propensity Score Matching for Sex Selection Bias 321
After the SERVE-HF Trial, Is There Still a Need for Treatment of Central Apnea? 319
Abnormal ventricular repolarization in hypertensive patients: role of sympatho-vagal imbalance and left ventricular hypertrophy 319
Glycosylated haemoglobin is associated with neurohormonal activation and poor outcome in chronic heart failure patients with mild left ventricular systolic dysfunction 319
Amyloid seeding as a disease mechanism and treatment target in transthyretin cardiac amyloidosis 318
Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy 318
Acute right-sided transcutaneous vagus nerve stimulation improves cardio-vagal baroreflex gain in patients with chronic heart failure 317
Incremental prognostic value of myocardial fibrosis in patients with non-ischemic cardiomyopathy without congestive heart failure 317
Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study 317
RNA-targeting and gene editing therapies for transthyretin amyloidosis 316
[Rationale and significance of the Italian Network for Cardiac Amyloidosis] 316
Biomarcatori di stabilità della placca aterosclerotica (Rassegna) 316
Prognostic Value of Soluble Suppression of Tumorigenicity-2 in Chronic Heart Failure: A Meta-Analysis 316
CHADS2 and CHA2DS2-VASc scores to predict morbidity and mortality in heart failure patients candidates to cardiac resynchronization therapy 316
Admission high-sensitivity troponin T and NT-proBNP for outcome prediction in acute heart failure 316
A mechanistic look at sacubitril/valsartan action. Unravelling magician's secrets 316
Using co-creation to develop a cardiology online open course: an effective approach for implementing digital learning 315
Valutazione delle caratteristiche analitiche di un nuovo metodo di dosaggio del BNP 315
Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure: An Individual Patient Data Meta-Analysis 315
A prognostically meaningful definition of non-dilated left ventricular cardiomyopathy 314
An analysis of fMRI signal during voluntary breath hold and carbon dioxide challenge: physiological correction and modeling issues 312
A matter of sex—persistent predictive value of MECKI score prognostic power in men and women with heart failure and reduced ejection fraction: a multicenter study 311
Echocardiography-Derived Forward Left Ventricular Output Improves Risk Prediction in Systolic Heart Failure 311
Totale 42.627
Categoria #
all - tutte 946.364
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 946.364


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20226.107 0 0 0 889 180 250 922 1.669 502 941 138 616
2022/20235.887 547 376 172 845 776 931 52 486 1.037 118 330 217
2023/20244.142 345 129 800 249 173 445 352 194 212 202 162 879
2024/202534.849 265 325 1.822 648 1.291 1.781 4.145 7.450 2.628 3.805 6.753 3.936
2025/202686.022 4.277 13.594 10.172 10.737 8.516 5.099 8.838 3.744 5.070 5.490 5.087 5.398
2026/202717.243 2.362 2.871 5.327 6.683 0 0 0 0 0 0 0 0
Totale 190.159